Wireless Brain Drug Delivery Device
- Researchers at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) in South Korea have developed a flexible wireless neural interface capable of delivering drugs directly to deep...
- Led by professor Kyung-In Jang of the department of robotics and mechatronics engineering, the team designed the device using soft materials to maximize compatibility with neural tissue.
- To enhance delivery accuracy, the researchers drew inspiration from peristalsis - the wave-like muscular contractions of the gastrointestinal tract.
“`html
Flexible Wireless Neural Interface for Targeted Drug Delivery
Table of Contents
- Flexible Wireless Neural Interface for Targeted Drug Delivery
What is the New Neural Interface?
Researchers at the Daegu Gyeongbuk Institute of Science and Technology (DGIST) in South Korea have developed a flexible wireless neural interface capable of delivering drugs directly to deep brain regions.This fully implantable device aims to address the limitations of conventional drug infusion methods that rely on external equipment.
Mimicking the Body’s Natural Peristalsis for Precise Drug Delivery
Led by professor Kyung-In Jang of the department of robotics and mechatronics engineering, the team designed the device using soft materials to maximize compatibility with neural tissue. The device integrates a micro-pump and a microchannel system to precisely control drug infusion while minimizing the risk of backflow.
To enhance delivery accuracy, the researchers drew inspiration from peristalsis – the wave-like muscular contractions of the gastrointestinal tract. this principle is implemented thru a pump structure that drives a unidirectional flow via a sloped nozzle-diffuser channel, ensuring drug transport without reverse leakage. A wireless module is also incorporated, enabling real-time control of both infusion rate and dosage.
Peristalsis Explained
The involuntary contraction and relaxation of muscles in the digestive tract, creating a series of coordinated, wave-like muscle contractions that move food and other substances through the intestine.
Flexible Architecture for Enhanced Biocompatibility
The implant’s flexible architecture is achieved through the use of soft materials, ensuring good compatibility with brain tissues and facilitating stable insertion and operation.
Device Performance Validated in a brain Phantom
To assess its performance, the researchers utilized a “brain phantom” composed of agarose gel. These tests demonstrated consistent drug delivery without backflow. The wireless interface allowed for remote modulation of dosage, providing precise control over infusion rates.
Potential Applications and Future Directions
This technology holds promise for treating a variety of neurological disorders, including Parkinson’s disease, epilepsy, and chronic pain. The ability to deliver drugs directly to affected brain regions could substantially improve treatment efficacy and reduce side effects. Future research will focus on:
- In vivo testing: Evaluating the device’s performance and biocompatibility in living animal models.
- Drug compatibility: Assessing the device’s compatibility with a wider range of therapeutic drugs.
- Long-term stability: Investigating the long-term performance and durability of the implant.
- Miniaturization: further reducing the size of the device for less invasive implantation.